Rael T. Lange, Ph.D., British Columbia Mental Health and Addiction Services, “Neuropsychological and neuropathological effects of acute versus chronic alcohol consumption: Outcome from traumatic brain injury.” Approved for $50,000 for the first of two years.

Chiang-shan Ray Li, M.D., Ph.D., Yale University School of Medicine, “Inhibitory control and alcohol dependence.”  Approved for $49,800 for the first of two years.

Melissa A. Lewis, Ph.D., University of Washington, “Personalized Alcohol and Related Risky Sexual Behavior Feedback Intervention Project.” Approved for $50,000 for the first of two years.

Susan E. Luczak, Ph.D., University of Southern California, “Real-time assessment of alcohol involvement across ALDH2 genotypes.”  Approved for $50,000 for the second of two years.

James MacKillop, Ph.D., Brown University, “Understanding craving for alcohol via behavioral economics” Approved for $50,000 for the first of two years.

Krisztina Malisza, Ph.D., Institute for Biodiagnostics, “Stop, Look and Remember – Neuroimaging Cognitive Function in Children with ARND and ADHD.” Approved for $50,000 (Can) for the first of two years.

Lori Keyser-Marcus, Ph.D., Virginia Commonwealth University, “Detecting problem drinking in new mothers: concordance between interviewer and computer-delivered screening methods.” Approved for $50,500 for the second of two years.

Matthew P. Martens, Ph.D., University of Memphis, “The Effects of Personalized Drinking Feedback Programs among Intercollegiate Athletes.” Approved for $50,000 for the second of two years.

James G. Murphy, Ph.D., The University of Memphis, “Behavioral Economic Moderators of Brief Alcohol Interventions in a Diverse Sample of College Students.” Approved for $50,000 for the first of two years.

Dan J. Neal, Ph.D., Kent State University, “Self-Regulation, Alcohol Use and Alcohol-Related Consequences: An Electronic Diary Study.” Approved for $47,500 for the second of two years.

Edward Perry, Ph.D., Yale University School of Medicine, “Interactive psychopharmacologic effects of alcohol and nicotine in humans.”  Approved for $50,000 for the second of two years.

Ralph Radach, Ph.D., Florida State University, “Visuomotor impairments due to acute alcohol intoxication,” Approved for $51,500 for the first of two years.

Jennifer Read, Ph.D., State University of New York at Buffalo, “Trauma, PTSD, and Alcohol Information Processing in College Students.” Approved for $45,500 for the first of two years. 

Karmen K. Yoder, Ph.D., Indiana University, “Imaging the Dopamine Response to Alcohol in Nontreatment-Seeking Alcoholics.” Approved for $50,000 for the first of two years.

Arpana Agrawal, Ph.D., Washington University School of Medicine, “Gene x Environment Influences on Quantitative Indices of Alcohol Consumption.” Approved for $49,500 for the first of two years.

Cynthia Czajkowski, Ph.D., University of Wisconsin at Madison, “Mapping the Ethanol Binding Site on alpha4-beta-delta GABA-A Receptors.” Approved for $50,000 for the second of two years.

Lynette C. Daws, Ph.D., University of Texas Health Science Center at San Antonio, “Alcohol Inhibits Serotonin Clearance in a Serotonin Transporter Independent Manner: Are Organic Cation Transporters the Missing Link?” Approved for $50,000 for the second of two years.

Olayinka Dina, D.V.M., Ph.D., University of California San Francisco, “Catecholamine mechanisms in alcohol-induced neuropathy.”  Approved for $49,000 for the second of two years.

Dee Harrison-Findik, Ph.D., University of Nebraska Medical Center, “Molecular mechanisms of short-term, moderate alcohol exposure-mediated regulation of hepcidin and iron metabolism in vivo.” Approved for $50,000 for the first of two years.

Ian N. Hines, Ph.D., The University of North Carolina at Chapel Hill, “Modulation of Hepatic Natural Killer T Cell Function by Ethanol.” Approved for $50,000 for the first of two years.

F. Woodward Hopf, Ph.D., Ernest Gallo Clinic and Research Center, “I_SKCa2+ Activation and the Dorsal Striatum: A Potential Novel Treatment for Alcohol Seeking.” Approved for $25,000 for the second of two years.

Makio Iwashima, Ph.D., Medical College of Georgia, “Alcohol induced regulatory T cell expansion.” Approved for $50,000 for the second of two years.

Hongbo R. Luo, Ph.D., Children’s Hospital Boston, “Molecular Basis of Alcohol-Induced Neutrophil Chemotaxis Defect.” Approved for $50,000 for the first of two years.

Frank L. Margolis, Ph.D., University of Maryland School of Medicine, “Neuronal loss and replacement after ethanol and abstinence.” Approved for $50,000 for the second of two years.

Andrzej Pietrzykowski, M.D., Ph.D., University of Massachusetts Medical School, “miRNA Regulation of Alcohol Actions in Mammalian Brain.” Approved for $50,000 for the second of two years.

Donita L. Robinson, Ph.D., University of North Carolina at Chapel Hill, “Neurophysiological adaptations in the nucleus accumbens to chronic and repeated ethanol exposure.” Approved for $50,000 for the first of two years.

Gregg Roman, Ph.D., University of Houston, “The Neuromodulation of Ethanol Sedation by Heterotrimeric G proteins in Drosophila.” Approved for $49,300 for the first of two years.

Tuan D. Tran, Ph.D., East Carolina University, “Critical periods of fetal alcohol exposure and effects on cerebellar-dependent learning and neuroanatomy.” Approved for $50,000 for the first of two years.

Janice Zabolotny, Ph.D., Beth Israel Deaconess Medical Center, “Role of PTP1B overexpression in pathogenesis of alcoholic fatty liver disease.” Approved for $50,000 for the first of two years.

Huiping Zhang, Ph.D., Yale University School of Medicine, “Association Study of a Subfamily (Rz) of Regulator of G-protein Signaling (RGS) Genes in Alcohol Dependence.”  Approved for $50,000 for the first of two years.